incTANK Ventures

Revela Biotech is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing an ImmunoPET imaging solution aimed at enhancing cancer diagnosis and treatment. This innovative platform technology focuses on characterizing cancer tumors to identify the most effective immune-oncology therapies. Additionally, Revela Biotech is engaged in creating single-domain antibody fragments that provide doctors with improved specificity and sensitivity for treating various cancers. The company's advancements also assist pharmaceutical companies by enhancing tissue penetration and offering cost-effective manufacturing solutions.

Tiba Biotech is a Boston-based pre-clinical biotechnology company focused on developing innovative vaccines and immunotherapies for both human and animal diseases. The company utilizes its expertise in synthetic biology and chemistry to create more effective and cost-efficient solutions. Tiba Biotech has developed a programmable ribonucleic acid (RNA) vaccine platform that revolutionizes existing design, delivery, and biomanufacturing processes. This platform enables the rapid development of highly effective vaccines against a variety of diseases, ensuring that patients have access to safer, more effective, and affordable nucleic acid products. The company's vision is to facilitate the creation of affordable vaccines and therapeutics that can be swiftly developed in response to epidemics and specific patient needs, thereby reducing the reliance on lengthy biomanufacturing processes.

Elemental Machines, Inc., founded in 2014 and based in Cambridge, Massachusetts, specializes in providing a smart lab platform designed to enhance laboratory operations in science-based industries. The company's innovative technology continuously monitors equipment and environmental variables, delivering data-driven insights that foster improved research, development, and manufacturing outcomes. By utilizing intelligent sensors, the platform visualizes the entire testing environment and issues alerts for any anomalous results, thereby ensuring experimental reproducibility. This capability allows clients to refine and accelerate their work across all phases of product innovation, ultimately leading to greater clarity, transparency, and consistency in laboratory processes.

Misfit Wearables, founded in 2011 and headquartered in Burlingame, California, specializes in creating innovative wearable devices aimed at enhancing consumer health and fitness. The company focuses on developing products that encourage users to adopt active lifestyles and cultivate healthy habits. One of its flagship offerings is the Shine, a sleek personal activity tracker that effortlessly syncs with smartphones. As a pioneer in the wearable sensor technology sector, Misfit is dedicated to producing stylish and functional devices that people will want to wear consistently.

Ligon Discovery Inc., established in 2007 and headquartered in Cambridge, Massachusetts, specializes in drug discovery services focused on oncology and coagulation disorders. The company employs Small-Molecule Microarrays (SMMs), a proprietary technology developed at Harvard University and the Broad Institute, to identify drugs using small molecule microarray screening. Ligon offers screening services to pharmaceutical, biotechnology, and academic institutions, discovering small molecules with applications in diagnostics, imaging, and drug targeting. Their platform enables minimal protein requirement and chemical collection follow-up services, facilitating rapid identification of optimal small molecules for drug development.

Agrivida, Inc. is a biotechnology company specializing in animal health and nutrition through the development of innovative feed additives for poultry, swine, dairy and beef cattle, and aquaculture. Founded in 2003 and based in Four Seasons, Missouri, Agrivida utilizes its proprietary GRAINZYME technology to produce enzymes directly within corn kernels, offering a natural and effective method to enhance animal diets. This platform enables the integration of beneficial enzymes such as phytase and glucanase, which improve nutritional efficiency and reduce the environmental impact of livestock production. Agrivida's solutions aim to promote healthier food production while delivering economic benefits to its clients in the agricultural sector.

AgaMatrix, Inc. is a company focused on developing and manufacturing advanced biosensors and blood glucose monitoring systems for individuals with diabetes. Established in 2001 and headquartered in Salem, New Hampshire, AgaMatrix offers an array of products designed to enhance diabetes care, including mobile blood glucose meters and data management software. One of its key innovations is the WaveSense technology, which personalizes testing by improving accuracy and correcting for potential errors arising from variations in blood samples and environmental conditions. The company also provides the AgaMatrix Diabetes Manager, which consolidates tracking of glucose, insulin, carbohydrates, and weight, as well as the Zero-Click system for streamlined data management. With a strong portfolio of over 160 patents covering its technologies, AgaMatrix partners with notable firms such as Biocorp Production and Sanofi to distribute its products through retail channels.

Agrivida, Inc. is a biotechnology company specializing in animal health and nutrition through the development of innovative feed additives for poultry, swine, dairy and beef cattle, and aquaculture. Founded in 2003 and based in Four Seasons, Missouri, Agrivida utilizes its proprietary GRAINZYME technology to produce enzymes directly within corn kernels, offering a natural and effective method to enhance animal diets. This platform enables the integration of beneficial enzymes such as phytase and glucanase, which improve nutritional efficiency and reduce the environmental impact of livestock production. Agrivida's solutions aim to promote healthier food production while delivering economic benefits to its clients in the agricultural sector.